Wednesday, June 15, 2016 9:36:03 PM
K= kevetrin B= brilacidin P= prurisol
CTIX Clinicals, FDA, Milestones
10/5/12 K Ph1 starts
10/9/13 Acquired Poly assets
2/24/14 B/ABSSSI Ph2b starts
3/24/14 P Ph1 crossover study starts
8/7/14 B/ABSSSI meets Ph2b endpoints
10/13/14 B/OM Ph2 approval to commence
12/10/14 B/ABSSSI granted QIDP designation
12/10/14 P Ph2 start approved by FDA
5/22/15 K Ph1 allowed additional patient enrollment
7/20/15 K granted OrphanDrug Designation for Ovarian cancer
8/6/15 P Ph2 commences
11/23/15 K for Retinoblastoma (eye cancer) receives OrphanDrug Designation
11/25/15 B/OM granted FDA Fast Track Designation
12/1/15 K granted "Rare Pediatric Disease Designation" for Retinoblastoma
1/21/16 K receives Orphan Drug (FDA) Designation for Pancreatic Cancer
Applying for grants with research partner ?Mayo Clinic?
2/10/16 K approved for Ph2 ovarian cancer trial
2/16/16 K Ph1 trial formally concludes
2/22/16 K Ph1 early data-Increased p21 Expression in 67.5% of Evaluable Patients
3/17/16 P ph2 last patient dosed
5/31/16 P ph2 successful trial data released
6/9/16 K ph1 hard lock of data
6/10/16 Rosen/scam lawsite dismissed by court.
6/15/16 B ph2 ulcerative proctitis 6 week duration overseas trial begins
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM